Front Line Genomics invites you to their event

Next-Generation PCR ONLINE: PCR in pathogen detection & diagnostics

About this event

The advent of PCR methods has enabled the detection and quantification of nucleic acids in small sample sizes. Just recently, PCR technologies were placed on the frontline in our fight against the COVID-19 pandemic, when RT-qPCR methods were deployed as part of the diagnostic testing response.

Additionally, digital PCR (dPCR) represents a major step forward in the absolute quantification of nucleic acids. This technology is particularly useful in low abundance targets. With applications in liquid biopsy, copy number variation detection and pathogen detection, this technology has the potential to heavily impact genomic research. However, challenges such as accuracy, reproducibility, assay optimization and translation can prevent the use of these technologies in the clinic.

Join us for this unique 3-part webinar series, as we highlight how next-generation PCR methods can impact modern science, and how we are addressing the challenges related to the use of these technologies.

Webinar 1: Advancing dPCR for various applications.

11th March, 3pm GMT/ 4pm CET/ 11am EST

This webinar will cover how we are improving the ways we approach dPCR for various applications, and how we are addressing the challenges associated with the use of this technology.

Digital High-Resolution Melting for improved dPCR quantification and pathogen detection – Stephanie Fraley, Associate Professor, Bioengineering, UC San Diego

Comparison of digital PCR to NGS for monitoring mitochondrial carryover after nuclear transfer for in-vitro fertilization – Ward de Spiegelaere, Assistant Professor, University of Ghent

The naica® system – a flexible dPCR assay development platform - Jean Fatien, M.Eng. Biomed - R&D Scientist, Stilla Technologies

Webinar 2: Applications of dPCR in liquid biopsy and cancer monitoring

18th March, 3pm GMT/ 4pm CET/ 11am EDT

dPCR is particularly helpful in helping to quantify nucleic acids at a low frequency. With isolating ctDNA from a simple blood draw being likened to finding a needle in a haystack, improving our ability to detect these biomarkers in blood can improve the way we diagnose and monitor cancers forever.

This webinar will focus on the applications of dPCR in liquid biopsies, as well as future developments for these to be used routinely.

Ensuring the reliability of ctDNA results for clinical applications - Valerie Taly, Group Leader, INSERM

Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors – Ed Schuuring, Professor of Molecular Oncological Pathology, University Medical Centre Groningen

The implementation of dPCR in liquid biopsy and its considerations - Daniel Lofgren, Market Development Manager, Digital PCR, EMEA, QIAGEN

Webinar 3: PCR in pathogen detection & diagnostics

25th March, 3pm GMT/ 4pm CET/ 11am EDT

The COVID-19 pandemic has put a specific emphasis on the ability of genomic tracking of infectious diseases. When the pandemic began, PCR technologies were at the forefront of our fight to detect COVID-positive patients as part of the response to stop the spread of Coronavirus.

This webinar will focus on the diagnostic applications of PCR methods in infectious diseases, and how they are being optimised.

Interested in counting viruses and bacteria? – Mojca Milavec, Research Councillor, National Institute of Biology

Rapid nucleic acid diagnostics for SARS-CoV-2 – Stephen Bustin, Professor of Molecular Medicine, Anglia Ruskin University

ddPCR & NGS for viral genome copies determination. A case study - Luisa Marena, Senior Scientist – Head of Innovative Cell Line Characterization Lab, Merck

Hosted by

  • Team member
    CH T
    Celine Hashweh Front Line Genomics

  • Guest speaker
    LM G
    Luisa Marena Senior scientist @ Merck

  • Guest speaker
    SB G
    Stephen Bustin

  • Guest speaker
    MM G
    Mojca Milavec

Front Line Genomics

Delivering the Benefits of Genomics to Patients Faster

Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.